Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
46,847,791
-
Share change
-
+4,599,588
-
Total reported value
-
$657,293,219
-
Put/Call ratio
-
134%
-
Price per share
-
$14.03
-
Number of holders
-
179
-
Value change
-
+$62,276,957
-
Number of buys
-
107
-
Number of sells
-
74
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2015
As of 30 Sep 2015 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 46,847,791 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, BlackRock Fund Advisors, STATE STREET CORP, Invesco Ltd., Ranger Investment Management, L.P., Apex Capital Management, VANGUARD GROUP INC, GLENMEDE TRUST CO NA, Murphy Michael R, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 179 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.